menu
    • menu

    Company profile for Autobahn Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to improve life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of these conditions by returning the brain to a healthier state will transcend the benefits offered by existing therapies and allow people to live the futures they deserve.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Autobahn TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9880 Campus Point Drive, San Diego CA
    Telephone
    Telephone
    (858) 722-0037
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://autobahntx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/autobahn-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Autobahn Therapeutics Unveils Elunetirom's Neuroplasticity
    Autobahn Therapeutics Unveils Elunetirom's Neuroplasticity

    16 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-16/autobahn-therapeutics-presents-new-preclinical-data-at-acnp-annual-meeting-supporting-novel-restorat

    PHARMIWEB
    16 Jan 2026
    Share Share
    Autobahn Therapeutics at 44th Annual JPM Healthcare Conference
    Autobahn Therapeutics at 44th Annual JPM Healthcare Conference

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217764141/en/Autobahn-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    Autobahn Labs & Astellas Partner To Speed Academic Discoveries
    Autobahn Labs & Astellas Partner To Speed Academic Discoveries

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203807/0/en/Autobahn-Labs-Forms-Strategic-Partnership-with-Astellas-to-Accelerate-Academic-Discoveries-into-New-Medicines.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    Autobahn Therapeutics To Join 2025 Jefferies London Health Conf
    Autobahn Therapeutics To Join 2025 Jefferies London Health Conf

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110436223/en/Autobahn-Therapeutics-to-Participate-in-2025-Jefferies-London-Healthcare-Conference

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Autobahn Therapeutics to Participate in Investor Conferences
    Autobahn Therapeutics to Participate in Investor Conferences

    25 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-25/autobahn-therapeutics-to-participate-in-multiple-upcoming-investor-conferences

    PHARMAWEB
    25 Aug 2025
    Share Share
    Autobahn Joins Evercore Emerging Biotech Conference
    Autobahn Joins Evercore Emerging Biotech Conference

    08 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250708962590/en/Autobahn-Therapeutics-to-Participate-in-Evercores-Emerging-Private-Biotech-Conference

    BUSINESSWIRE
    08 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search